Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Digital Biomarker and Omics-Based Assessment of Surgical Resiliency in Children Undergoing Solid Tumor Resection: A Pilot Feasibility Study

NCT06674811 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06674811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06674811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Digital Biomarker and Omics-Based Assessment of Surgical Resiliency in Children Undergoing Solid Tumor Resection: A Pilot Feasibility Study
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
January 15, 2025
Completion date
January 31, 2030
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

childhood bone sarcoma, childhood malignant intestinal neoplasm, childhood malignant liver neoplasm, childhood malignant lung neoplasm, childhood malignant ovarian neoplasm, childhood malignant pleural neoplasm, childhood neuroblastic tumor, childhood sarcoma, childhood soft tissue sarcoma, neuroblastoma, pediatric cancer, sarcoma, wilms tumor and other childhood kidney tumors